Bright Minds BiosciencesDRUG
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 31 institutions reported holding Bright Minds Biosciences Inc. (DRUG) in their 13F filings, up 25 from Q3 2024. 23 opened new positions and 1 sold out. The largest holders were Cormorant Asset Management, LP ($38.2M), Janus Henderson Group PLC ($18.4M) and Commodore Capital LP ($18.0M). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bright Minds Biosciences Inc.
- CUSIP
- 10919W405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 23 | $173.7M |
| Exits | 1 | $117 |
All 13F filers, Q3 2024 → Q4 2024: 4,829,084 shares bought and 184,312 shares sold, net +4,644,772 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Cormorant Asset Management, LP | 2.10% | New | 1,059,331 | $38.2M |
| Janus Henderson Group PLC | 0.01% | New | 508,776 | $18.4M |
| Commodore Capital LP | 1.32% | New | 500,000 | $18.0M |
| Ra Capital Management, L.P. | 0.22% | New | 460,829 | $16.6M |
| Sio Capital Management, LLC | 4.58% | New | 451,793 | $16.3M |
| Perceptive Advisors LLC | 0.41% | New | 403,649 | $14.5M |
| Vivo Capital, LLC | 1.02% | New | 251,572 | $9.1M |
| Logos Global Management LP | 1.03% | New | 245,000 | $8.8M |
| Morgan Stanley | 0.00% | New | 167,640 | $6.0M |
| Ikarian Capital, LLC | 1.57% | New | 152,211 | $5.5M |
| Point72 Asset Management | 0.01% | New | 135,189 | $4.9M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | New | 132,500 | $4.8M |
| Walleye Capital LLC | 0.04% | New | 103,192 | $3.7M |
| Acuta Capital Partners, LLC | 2.51% | New | 69,124 | $2.5M |
| Schonfeld Strategic Advisors LLC | 0.02% | New | 69,812 | $2.5M |
| Springhill Fund Asset Management (HK) Co Ltd | 3.55% | — | 60,648 | $2.2M |
| Boothbay Fund Management, LLC | 0.05% | New | 44,580 | $1.6M |
| Millennium Management | 0.00% | New | 40,379 | $1.5M |
| Atika Capital Management LLC | 0.07% | New | 15,000 | $540K |
| UBS Group AG | 0.00% | Add +198.2% | 10,161 | $366K |
| Jane Street Group, LLC | 0.00% | New | 6,600 | $238K |
| Bank of America Corp. | 0.00% | New | 4,793 | $173K |
| AdvisorShares Investments LLC | 0.02% | Reduce -98.3% | 3,075 | $111K |
| Royal Bank of Canada | 0.00% | Add +23.9% | 818 | $29K |
| Osaic Holdings, Inc. | 0.00% | New | 175 | $6K |
| National Bank of Canada | 0.00% | Reduce -98.1% | 92 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 55 | $2K |
| US Bancorp \de | 0.00% | New | 26 | $937 |
| R Squared Ltd | 0.00% | — | 10 | $360 |
| Citigroup Inc. | 0.00% | New | 1 | $36 |
| BlackRock, Inc. | 0.00% | No change | 1 | $36 |
"% of holder's portfolio" is DRUG's weight in each manager's 13F, not the share of Bright Minds Biosciences Inc. the manager owns.